We found that ABRO1 messenger RNA was significantly downregulated in tumour samples derived from the thyroid gland (eight of ten), liver (three of three), kidney (five of ten) and breast (five of ten) (Supplementary Fig. 1a). The gene discussed is ABRAXAS2; the disease is neoplasm.